3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide

C14H25N5O — CID 62938766

IUPAC3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide
SMILES[H]/N=C(\N)CCN(c1nccn(C(C)(C)C)c1=O)C(C)C
InChIInChI=1S/C14H25N5O/c1-10(2)18(8-6-11(15)16)12-13(20)19(9-7-17-12)14(3,4)5/h7,9-10H,6,8H2,1-5H3,(H3,15,16)
InChIKeyQBHBIKCWVCWWHC-UHFFFAOYSA-N
MW279.39 g/mol
LogP1.54
Rot. Bonds5

About 3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide

3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide (PubChem CID 62938766) has the molecular formula C14H25N5O and a molecular weight of 279.39 g/mol. Its IUPAC name is 3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide.

Molecular Properties

Compound Name3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide
PubChem CID62938766
Molecular FormulaC14H25N5O
Molecular Weight279.39 g/mol
Exact Mass279.21
IUPAC Name3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide
SMILES[H]/N=C(\N)CCN(c1nccn(C(C)(C)C)c1=O)C(C)C
InChIInChI=1S/C14H25N5O/c1-10(2)18(8-6-11(15)16)12-13(20)19(9-7-17-12)14(3,4)5/h7,9-10H,6,8H2,1-5H3,(H3,15,16)
InChIKeyQBHBIKCWVCWWHC-UHFFFAOYSA-N
XLogP1.54
TPSA88.00 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms20
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500279.39
LogP ≤ 51.54
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-[(4-ethyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide
CID 62938598
3-[(3-fluoro-2-pyridinyl)-propan-2-ylamino]propanimidamide
CID 62733411
3-[2-aminoethyl(pentan-3-yl)amino]-1-tert-butylpyrazin-2-one
CID 63761014
3-[[4-(2-methylpropyl)-3-oxopyrazin-2-yl]-propan-2-ylamino]propanethioamide
CID 62939107
3-[2-methylpropyl-(3-oxo-4-propylpyrazin-2-yl)amino]propanimidamide
CID 62939297
3-[ethyl-(4-methyl-3-oxopyrazin-2-yl)amino]propanimidamide
CID 62940592
3-[3-bromobutyl(methyl)amino]-1-tert-butylpyrazin-2-one
CID 113499996
3-[3-aminopropyl(methyl)amino]-1-tert-butylpyrazin-2-one
CID 55155444
3-[cyclopropyl-(3-oxo-4-propylpyrazin-2-yl)amino]propanimidamide
CID 55156215
3-[propan-2-yl-[4-(trifluoromethyl)-2-pyridinyl]amino]propanimidamide
CID 66328661
3-[methyl-[(1-methylimidazol-2-yl)methyl]amino]propanimidamide
CID 63013799
2-[(4-tert-butyl-3-oxopyrazin-2-yl)-propylamino]acetic acid
CID 62939610

Frequently Asked Questions

What is the IUPAC name of 3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide?
The IUPAC name of 3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide (CID 62938766) is 3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide.
What is the SMILES notation for 3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide?
The canonical SMILES for 3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide is [H]/N=C(\N)CCN(c1nccn(C(C)(C)C)c1=O)C(C)C.
What is the InChIKey of 3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide?
The InChIKey is QBHBIKCWVCWWHC-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H25N5O/c1-10(2)18(8-6-11(15)16)12-13(20)19(9-7-17-12)14(3,4)5/h7,9-10H,6,8H2,1-5H3,(H3,15,16).
What are the key properties of 3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide?
3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide has a molecular weight of 279.39 g/mol, XLogP of 1.54, 5 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(4-tert-butyl-3-oxopyrazin-2-yl)-propan-2-ylamino]propanimidamide is sourced from PubChem (CID 62938766), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).